CPT code 67208 denotes the destruction of a retinal lesion using extreme cold or hot temperatures, a focal therapeutic procedure used in ophthalmology to ablate abnormal retinal tissue. Nationally, this code is relevant for clinicians who treat retinal tumors, vascular lesions, and other localized retinal pathologies that require thermal or cryogenic destruction. Proper coding affects clinical documentation, facility and professional billing, and coverage determinations across major payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical intent of the procedure, typical sites of service, and the elements that influence billing and coverage decisions. The publication provides benchmarks for utilization and reimbursement where available, highlights relevant policy updates affecting prior authorization and coverage, and summarizes clinical context that influences coding choices. Data on associated modifiers, taxonomies, and diagnosis coding are noted where available; if specific inputs were not provided, the report indicates that data are not available in the input. This resource is intended for billing managers, ophthalmology providers, and policy analysts seeking a national-level briefing on CPT code 67208 and its application in routine retinal practice.